Obsidian Therapeutics Funding: $200M Raised, Series C (2023)
Obsidian Therapeutics is a Biotech company based in Cambridge, MA. It has raised $200M in total funding. Latest round: Series C.
Obsidian Therapeutics funding overview
Obsidian Therapeutics is a Biotech company based in Cambridge, MA. Obsidian Therapeutics has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2023. The round record for Obsidian Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include GV, Atlas Venture, Takeda Ventures, Vertex Ventures HC, Amgen Ventures, Wellington Management and 5 others. 11 distinct backers are named across the disclosed rounds.
Frequently asked about Obsidian Therapeutics funding
How much has Obsidian Therapeutics raised?
Obsidian Therapeutics has raised $200M in total disclosed funding across the rounds on record.
Who has invested in Obsidian Therapeutics?
GV, Atlas Venture, Takeda Ventures, Vertex Ventures HC, Amgen Ventures, Wellington Management are named among the investors backing Obsidian Therapeutics.
What was the latest Obsidian Therapeutics funding round?
The most recent disclosed round is a Series C, announced in January 2023.
Where is Obsidian Therapeutics based?
Obsidian Therapeutics is based in Cambridge, MA.
What sector does Obsidian Therapeutics operate in?
Obsidian Therapeutics is tracked under Biotech from Cambridge, MA, with $200M in disclosed funding.
When did Obsidian Therapeutics last raise?
The last disclosed Obsidian Therapeutics round closed in January 2023 at Series C.
Every Obsidian Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Cambridge at a similar stage.
